---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-122878"
form_type: "8-K"
ticker: "HOOK"
cik: "0001760542"
company_name: "HOOKIPA Pharma Inc."
filed_at: "2023-12-01T23:59:59+00:00"
generated_at: "2026-06-07T19:27:15.990541+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# HOOKIPA Pharma designates Dr. Roman Necina as Chief Operations Officer effective Jan 1, 2024

## Summary
- Dr. Roman Necina, formerly Chief Development Officer, appointed Chief Operations Officer.
- Title change effective January 1, 2024; his existing employment contract remains unchanged.
- Necina served as Chief Development Officer since July 2022 and previously as Chief Technology Officer.

## SEC filing metadata
- accession: 0001104659-23-122878
- form_type: 8-K
- ticker: HOOK
- cik: 0001760542
- company_name: HOOKIPA Pharma Inc.
- filed_at: 2023-12-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1760542/000110465923122878/0001104659-23-122878-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1760542/000110465923122878/tm2331944d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-122878
- JSON: https://secwatch.observer/filing/0001104659-23-122878.json
- Plain text: https://secwatch.observer/filing/0001104659-23-122878.txt

## Key facts
- Executive change
  Dr. Roman Necina changed role as Chief Operations Officer at HOOKIPA Pharma Inc..
  - Action: changed title to
  - Role: Chief Operations Officer
  source text: changed the title of the Company’s current Chief Development Officer, Dr. Roman Necina, to Chief Operations Officer, effective January 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1760542/000110465923122878/0001104659-23-122878-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.